Biogen Paying $5.6B For Apellis As 4 Firms Advise
By Al Barbarino · March 31, 2026, 5:35 PM EDT
Biogen Inc. said Tuesday that it has agreed to acquire Apellis Pharmaceuticals Inc. in a cash transaction valued at about $5.6 billion, with four law firms steering the transaction focused on key...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login